NCEL
Price:
$2.55
Market Cap:
$1.15M
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.
Industry
Biotechnology
IPO Date
2025-10-24
Stock Exchange
NASDAQ
Ticker
NCEL
According to NewcelX Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is -1924876.00. This represents a change of -100.70% compared to the average of 275.22M of the last 4 quarters.
The mean historical Enterprise Value of NewcelX Ltd. over the last ten years is 722.23M. The current -1924876.00 Enterprise Value has changed -126.65% with respect to the historical average. Over the past ten years (40 quarters), NCEL's Enterprise Value was at its highest in in the June 2023 quarter at 1.68B. The Enterprise Value was at its lowest in in the December 2024 quarter at -1549345.00.
Average
722.23M
Median
774.02M
Minimum
-76565.00
Maximum
1.37B
Discovering the peaks and valleys of NewcelX Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 18.04%
Maximum Annual Enterprise Value = 1.37B
Minimum Annual Increase = -100.01%
Minimum Annual Enterprise Value = -76565.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | -76565.00 | -100.01% |
| 2023 | 898.64M | -10.73% |
| 2022 | 1.01B | 55.02% |
| 2021 | 649.40M | 16.15% |
| 2020 | 559.10M | -56.61% |
| 2019 | 1.29B | 18.04% |
| 2018 | 7.11M | -99.48% |
The current Enterprise Value of NewcelX Ltd. (NCEL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
635.08M
5-year avg
622.75M
10-year avg
722.23M
NewcelX Ltd.’s Enterprise Value is less than Ocean Biomedical, Inc. (11.02M), less than IMAC Holdings, Inc. (257.74K), less than Prenetics Global Limited (260.03M), less than Surrozen, Inc. (115.00M), less than CERo Therapeutics Holdings, Inc. (-1030781.00), less than SAB Biotherapeutics, Inc. (19.01M), less than BriaCell Therapeutics Corp. (5.44M), less than Nuwellis, Inc. (1.07M), less than Celularity Inc. (97.12M), less than Pasithea Therapeutics Corp. (2.28M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 11.02M | $652.49K | |
| 257.74K | $302.80K | |
| 260.03M | $271.19M | |
| 115.00M | $189.26M | |
| -1030781.00 | $60.27K | |
| 19.01M | $42.25M | |
| 5.44M | $20.16K | |
| 1.07M | $3.78M | |
| 97.12M | $30.48M | |
| 2.28M | $6.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NewcelX Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NewcelX Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is NewcelX Ltd.'s Enterprise Value?
What is the highest Enterprise Value for NewcelX Ltd. (NCEL)?
What is the 3-year average Enterprise Value for NewcelX Ltd. (NCEL)?
What is the 5-year average Enterprise Value for NewcelX Ltd. (NCEL)?
How does the current Enterprise Value for NewcelX Ltd. (NCEL) compare to its historical average?